Role of hypoxia-inducible factor-1α and survivin in breast cancer recurrence and prognosis

• Published in: Heliyon Vol. 9; no. 3; p. e14132
• Main Authors: Cao, Qian, Mushajiang, Munire, Tang, Cheng-qiong, Ai, Xiu-qing
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2023; Elsevier
• Subjects: Breast cancer; HIF-1α; Prognosis; Recurrence; Survivin; Recurrence; Breast cancer; HIF-1α; Prognosis; Survivin
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2023.e14132

To analyze the expression of hypoxia-inducible factor-1α (HIF-1α) and survivin in breast cancer, and different molecular subtypes of breast cancer and to assess their relationship with recurrence and prognosis. The expression levels of HIF-1α and survivin genes in breast cancer were investigated using bioinformatics. Their protein expression levels were then verified through immunohistochemistry (IHC), and their relationship with recurrence and prognosis was assessed. Expression levels of HIF-1α and survivin genes and proteins were increased in breast cancer tissues compared with normal tissues. Both were associated with clinical features of breast cancer and differentially expressed in different molecular subtypes of breast cancer, and both are related to the signal pathway of breast cancer growth and invasion. HIF-1α and survivin gene and protein expression levels were correlated, and both were associated with breast cancer recurrence (R = 0.380, P < 0.05; R = 0.673, P < 0.05, respectively). According to The Cancer Genome Atlas (TCGA) database, HIF1A and BIRC5 gene were not associated with breast cancer prognosis (P ≥ 0.05); however, HIF-1α and survivin protein were associated with recurrence patient's overall survival (OS) (P < 0.05). HIF-1α and survivin are highly expressed in breast cancer and can be used as potential biomarkers to predict recurrence and assess prognosis. [Display omitted]